tiprankstipranks
Advertisement
Advertisement

HURA Stock Latest News

TuHURA Biosciences Expands Revolving Credit Facility Utilization
Company AnnouncementsTuHURA Biosciences Expands Revolving Credit Facility Utilization
9d ago
8K
HURA
TuHURA Biosciences Expands Use of Revolving Credit Facility
PremiumCompany Announcements
TuHURA Biosciences Expands Use of Revolving Credit Facility
1M ago
8K
HURA
TuHURA Sets 2026 Virtual Annual Meeting, Proposal Deadlines
PremiumCompany Announcements
TuHURA Sets 2026 Virtual Annual Meeting, Proposal Deadlines
2M ago
8K
HURA
TuHURA Biosciences files IND application with FDA for study of TBS-2025
PremiumThe Fly
TuHURA Biosciences files IND application with FDA for study of TBS-2025
2M ago
HURA
TuHURA Biosciences Draws on New $50M Credit Facility
PremiumCompany Announcements
TuHURA Biosciences Draws on New $50M Credit Facility
2M ago
8K
HURA
Leverage, Covenants and Royalty Drain: Why Tuhura Biosciences’ Parkview Credit Deal Heightens Liquidity and Dilution Risks
PremiumCompany AnnouncementsLeverage, Covenants and Royalty Drain: Why Tuhura Biosciences’ Parkview Credit Deal Heightens Liquidity and Dilution Risks
3M ago
HURA
TuHURA Biosciences Extends Cash Runway and Advances Pipeline
Premium
Company Announcements
TuHURA Biosciences Extends Cash Runway and Advances Pipeline
3M ago
8K
HURA
TuHURA Biosciences initiated with an Outperform at Citizens
Premium
The Fly
TuHURA Biosciences initiated with an Outperform at Citizens
3M ago
HURA
TuHURA Biosciences Secures $50 Million Credit Facility
PremiumCompany Announcements
TuHURA Biosciences Secures $50 Million Credit Facility
4M ago
8K
HURA
TuHURA Biosciences initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
TuHURA Biosciences initiated with a Buy at Rodman & Renshaw
4M ago
HURA
TuHURA Biosciences Approves 2025 Executive Compensation Adjustments
PremiumCompany Announcements
TuHURA Biosciences Approves 2025 Executive Compensation Adjustments
4M ago
8K
HURA
TuHURA Biosciences files INDA for TBS-2025 in blood-related cancers
PremiumThe Fly
TuHURA Biosciences files INDA for TBS-2025 in blood-related cancers
6M ago
HURA
VOO vs. VTI vs. VTWO: Which Vanguard ETF Offers the Best Upside in 2026?
PremiumMarket NewsVOO vs. VTI vs. VTWO: Which Vanguard ETF Offers the Best Upside in 2026?
6M ago
BE
VOO
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/6/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/6/26
6M ago
CLB
IMA
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/4/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/4/26
6M ago
L
IMA
TuHURA Biosciences: Undervalued Orphan-Drug Oncology Pipeline with Multiple Near-Term Catalysts Supports Reiterated Buy and $10 Target
PremiumRatings
TuHURA Biosciences: Undervalued Orphan-Drug Oncology Pipeline with Multiple Near-Term Catalysts Supports Reiterated Buy and $10 Target
6M ago
HURA
TuHURA Biosciences says FDA grants Orphan Drug Designation to IFx-2.0
PremiumThe Fly
TuHURA Biosciences says FDA grants Orphan Drug Designation to IFx-2.0
6M ago
HURA
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice
PremiumCompany Announcements
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice
6M ago
8K
HURA
TuHURA Biosciences price target lowered to $10 from $12 at H.C. Wainwright
PremiumThe Fly
TuHURA Biosciences price target lowered to $10 from $12 at H.C. Wainwright
7M ago
HURA
TuHURA Biosciences announces release of Kintara’s CVR
PremiumThe FlyTuHURA Biosciences announces release of Kintara’s CVR
8M ago
HURA
TuHURA Biosciences provides updates across portfolio
Premium
The Fly
TuHURA Biosciences provides updates across portfolio
8M ago
HURA
TuHURA Biosciences Announces Securities Purchase Agreement
Premium
Company Announcements
TuHURA Biosciences Announces Securities Purchase Agreement
8M ago
8K
HURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >